Literature DB >> 16408097

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients.

J A Pérez-Simón, A Sureda, F Fernández-Aviles, A Sampol, J R Cabrera, D Caballero, R Martino, J Petit, J F Tomás, J M Moraleda, A Alegre, C Cañizo, S Brunet, L Rosiñol, J Lahuerta, J L Díez-Martín, A León, A García, L Vazquez, J Sierra, J F San Miguel.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16408097     DOI： 10.1038/sj.leu.2404085

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  24 in total

1.  Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma.

Authors:  Alexandra Gomez-Arteaga; Gunjan L Shah; Raymond E Baser; Michael Scordo; Josel D Ruiz; Adam Bryant; Parastoo B Dahi; Arnab Ghosh; Oscar B Lahoud; Heather J Landau; Ola Landgren; Brian C Shaffer; Eric L Smith; Guenther Koehne; Miguel-Angel Perales; Sergio A Giralt; David J Chung
Journal:  Biol Blood Marrow Transplant       Date:  2020-07-23       Impact factor: 5.742

2.  Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma.

Authors:  L Giaccone; L Brunello; M Festuccia; M Gilestro; E Maffini; F Ferrando; E Talamo; R Passera; M Boccadoro; P Omedè; B Bruno
Journal:  Bone Marrow Transplant       Date:  2015-02-09       Impact factor: 5.483

3.  Multiple Myeloma: A Rare Haematological Cause of Nasal Septal Perforation and a Vasculitis Mimic.

Authors:  Ankur Jain; Prasanth Balasubramaniam; Ram V Nampoothiri; Pankaj Malhotra; Alka Khadwal; Gaurav Prakash; Kim Vaiphai; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2016-10-08       Impact factor: 0.900

4.  Multiple myeloma relapse following autologous stem cell transplant presenting with diffuse pulmonary nodules.

Authors:  Bradley Sumrall; Lisa Diethelm; Archie Brown
Journal:  Ochsner J       Date:  2013

Review 5.  Extramedullary multiple myeloma.

Authors:  Manisha Bhutani; David M Foureau; Shebli Atrash; Peter M Voorhees; Saad Z Usmani
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

6.  Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.

Authors:  Alfred L Garfall; Edward A Stadtmauer; Wei-Ting Hwang; Simon F Lacey; Jan Joseph Melenhorst; Maria Krevvata; Martin P Carroll; William H Matsui; Qiuju Wang; Madhav V Dhodapkar; Kavita Dhodapkar; Rituparna Das; Dan T Vogl; Brendan M Weiss; Adam D Cohen; Patricia A Mangan; Emily C Ayers; Selene Nunez-Cruz; Irina Kulikovskaya; Megan M Davis; Anne Lamontagne; Karen Dengel; Naseem Ds Kerr; Regina M Young; Donald L Siegel; Bruce L Levine; Michael C Milone; Marcela V Maus; Carl H June
Journal:  JCI Insight       Date:  2018-04-19

Review 7.  Plasma cell leukaemia and other aggressive plasma cell malignancies.

Authors:  Taimur Sher; Kena C Miller; George Deeb; Kelvin Lee; Asher Chanan-Khan
Journal:  Br J Haematol       Date:  2010-08       Impact factor: 6.998

8.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  David L Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John Levine; David G Maloney; Karl Peggs; Jacob M Rowe; Alan S Wayne; Sergio Giralt; Michael R Bishop; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-10       Impact factor: 5.742

9.  In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma.

Authors:  Enrique M Ocio; David Vilanova; Peter Atadja; Patricia Maiso; Edvan Crusoe; Diego Fernández-Lázaro; Mercedes Garayoa; Laura San-Segundo; Teresa Hernández-Iglesias; Enrique de Alava; Wenlin Shao; Yung-Mae Yao; Atanasio Pandiella; Jesús F San-Miguel
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

10.  Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.

Authors:  Ludek Pour; Sabina Sevcikova; Henrieta Greslikova; Renata Kupska; Petra Majkova; Lenka Zahradova; Viera Sandecka; Zdenek Adam; Marta Krejci; Petr Kuglik; Roman Hajek
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.